You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023284013
Dec 20235907
Jan 20242202
Feb 20242202
Mar 20242202
Apr 20242401
May 20242204
Jun 20244705
Jul 20242400
Aug 20241202
Sep 20242206
Oct 20242403
Nov 202440010
Dec 20243007
Jan 20252008
Feb 2025403
Mar 2025002
Apr 2025001
May 2025002
Jun 2025004
Total678084